Blood Market By Application (Dermatology, Diabetes, Gastroenterology, Intracranial Monitoring In Stroke And Brain Injury, Peripheral Vascular Diseases, Tumour Monitoring And Angiogenesis), By Product (Electromagnetic Blood Flowmeters, Laser Doppler Blood Flowmeters, Ultrasonic Doppler Blood Flowmeters), Industry Size, Growth, Share And Forecast To 2022
Key Findings
The global blood market is expected to grow by CAGR of 9.27% during the forecasted period 2016-2022. The major factor contributing towards the growth in market isincreasing aging population and accumulative prevalence of peripheral vascular diseases. The increasing aging population is having a huge impact on the growth of global blood market. According to WHO, the world aged population has been expected to reach 2 billion by the end of 2050 which was 900 million in 2015. Now there are around 125 million people aged 80 years or more. By the end of 2050 almost 125 million people aged 80 years or more has been expected to reach in China alone and 434 million people across the globe. So increasing aging population is one of the major driving factor of global blood market.The accumulative prevalence of peripheral vascular diseasesis also increasing the growth in the global market. Around 8.5 million people in United States only suffer from peripheral vascular diseases, in which around 12-20% of the people are aged more than 60, accounted at approximately 1.7 million people aged above 60 years.The awareness level of general population about peripheral vascular diseasesregistered at approximately 25% of total population in U.S. only.However, the market is growing by various factors but there are some factors restricting the growth of global blood market such asstringent government regulations, compliance requirements and enactment of patient protection and affordable healthcare act, 2010.The rising demand from emerging countries offering plaintiff growth opportunities in the global blood market. The rising number of surgeries, rising medical tourism in such countries due to increasing demand for low cost treatment across the globe and presence of high quality healthcare at low cost. Thus the increasing demand from emerging countries is one of the major factor which is creating huge opportunity in the global blood market in forecasted period.
Market Segment Insight
The global blood market is segmented into application, product and geography. On the basis of application, the market is segmented into dermatology diabetes, gastroenterology, intracranial monitoring in stroke and brain injury, peripheral vascular diseases and tumor monitoring and angiogenesis.The productsegment is segmented electromagnetic blood flowmeters, laser doppler blood flowmeters and ultrasonic doppler blood flowmeters.
Regional Insight
Globally, the blood market is segmented intoNorth America, Europe, APAC and ROW. North America region holds the largest market share in the global bloodmarket followed by Europe. North American region is driven by the growing prevalence of peripheral vascular diseases in the region asin U.S. there are around 8.5 million people suffering from peripheral vascular diseases.The presence of some of the big key players who have been investing huge amount on the research and development of technology is also a major driver in this region. Asia Pacific has been expected to grow with the highest CAGR in the forecasted period 2016-2022. The growth in Asia Pacific region is majorly driven by the increasing number of surgeries in the region, rising prevalence of aging population etc. China and India are the major contributor in the growth of the Asia Pacific region. Both the countries have the largest population in the world in terms of aging population the China is projected to lead the global market followed by India. The availability of low cost treatment in the Asia Pacific region is also increasing the medical tourism in the region which is generating a huge potential for the blood market in the region.
Competitive Insights
Some of the keymarket playersAre Abbott Laboratories, Arjohuntleigh, Inc., Baxter International Inc., Bio-Rad Laboratories, Deltex Medical, Gf Health Products, Pfizer Inc. And Roche.Acquisitions, mergers, product development, joint ventures and expansions are the key strategies adopted by the market players to sustain in the market.On May16, 2016, Pfizer, Inc. entered into an agreement with Anacor Pharmaceuticals, Inc. the agreement is to acquire Anacor Pharmaceuticals for worth $5.2 billion approx. $99.25 per share in cash. The acquisition assist Pfizer and create huge opportunities to unmet medical need of large patient population who have mild to moderate atopic dermatitis, in which less number of safe topical treatments are available.
CHAP 1. METHODOLOGY & SCOPE 11
1.1. RESEARCH METHODOLOGY 11
1.2. RESEARCH SCOPE & ASSUMPTIONS 11
1.3. LIST OF DATA SOURCES 11
CHAP 2. EXECUTIVE SUMMARY 12
2.1. GLOBAL BLOOD MARKET SUMMARY & KEY BUYING CRITERIA 12
2.2. GLOBAL BLOOD MARKET OUTLOOK 12
2.3. MARKET SEGMENTATION ANALYSIS 12
2.4. MARKET SIZE AND GROWTH PROSPECTS 2012-2022 12
2.5. GLOBAL BLOOD MARKET VALUE CHAIN ANALYSIS 12
2.6. VENDOR LANDSCAPE 12
CHAP 3. GLOBAL BLOOD MARKET 13
3.1. MARKET DRIVER ANALYSIS 13
3.1.1. INCREASING AGING POPULATION 13
3.1.2. ACCUMULATIVE PREVALENCE OF PERIPHERAL VASCULAR DISEASES 13
3.1.3. GROWING DEMAND FOR NON-INVASIVE AND ADVANCE TECHNOLOGICAL DEVICES 13
3.2. MARKET RESTRAINT ANALYSIS 13
3.2.1. STRINGENT GOVERNMENT REGULATIONS OR COMPLIANCE REQUIREMENT 13
3.2.2. ENACTMENT OF PATIENT PROTECTION AND AFFORDABLE HEALTHCARE ACT, 2010 13
3.3. KEY OPPORTUNITIES 13
3.3.1. RISING CLINICAL APPLICATIONS OF THESE DEVICES 13
3.3.2. GROWING EMERGING MARKET 13
3.4. CHALLENGES 13
3.4.1. HIGH PRICE OF THE DEVICES 13
CHAP 4. INDUSTRY ANALYSIS 14
4.1. GLOBAL BLOOD MARKET– PORTER’S FIVE FORCE MODEL 14
4.2. GLOBAL BLOOD MARKET– PESTEL ANALYSIS 14
4.3. GLOBAL BLOOD MARKET– GAP ANALYSIS 14
CHAP 5. GLOBAL BLOOD MARKET BY APPLICATION 2012-2022 ($ MILLION) 15
5.1. GLOBAL DERMATOLOGY MARKET 2012-2022 ($ MILLION) 15
5.2. GLOBAL DIABETES MARKET 2012-2022 ($ MILLION) 15
5.3. GLOBAL GASTROENTEROLOGY MARKET 2012-2022 ($ MILLION) 15
5.4. GLOBAL INTRACRANIAL MONITORING IN STROKE AND BRAIN INJURY MARKET 2012-2022 ($ MILLION) 15
5.5. GLOBAL PERIPHERAL VASCULAR DISEASES MARKET 2012-2022 ($ MILLION) 15
5.6. GLOBAL TUMOUR MONITORING AND ANGIOGENESIS) MARKET 2012-2022 ($ MILLION) 15
CHAP 6. GLOBAL BLOOD MARKET BY PRODUCT 2012-2022 ($ MILLION) 16
6.1. GLOBAL ELECTROMAGNETIC BLOOD FLOWMETERS MARKET 2012-2022 ($ MILLION) 16
6.2. GLOBAL LASER DOPPLER BLOOD FLOWMETERS MARKET 2012-2022 ($ MILLION) 16
6.3. GLOBAL ULTRASONIC DOPPLER BLOOD FLOWMETERS MARKET 2012-2022 ($ MILLION) 16
CHAP 7. GLOBAL BLOOD MARKET REGIONAL OUTLOOK 2012-2022 ($ MILLION) 17
7.1. GLOBAL BLOOD MARKET BY REGION 2012-2022 ($ MILLION) 17
7.2. NORTH AMERICA 17
7.2.1. NORTH AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 17
7.2.2. NORTH AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 17
7.2.3. NORTH AMERICA MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 17
7.2.3.1. U.S. 17
7.2.3.1.1. U.S. MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 17
7.2.3.1.2. U.S. MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 17
7.2.3.2. CANADA 17
7.2.3.2.1. CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 17
7.2.3.2.2. CANADA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 17
7.3. EUROPE 17
7.3.1. EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 17
7.3.2. EUROPE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 17
7.3.3. EUROPE MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 17
7.3.3.1. GERMANY 17
7.3.3.1.1. GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 18
7.3.3.1.2. GERMANY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 18
7.3.3.2. UK 18
7.3.3.2.1. UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 18
7.3.3.2.2. UK MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 18
7.3.3.3. FRANCE 18
7.3.3.3.1. FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 18
7.3.3.3.2. FRANCE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 18
7.3.3.4. RUSSIA 18
7.3.3.4.1. RUSSIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 18
7.3.3.4.2. RUSSIA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 18
7.3.3.5. REST OF EUROPE 18
7.3.3.5.1. ROE MARKET ESTIMATES AND FORECAST2012-2022($MILLION) 19
7.3.3.5.2. ROE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022($MILLION) 19
7.4. ASIA PACIFIC 19
7.4.1. ASIA PACIFIC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 19
7.4.2. ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 19
7.4.3. ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 19
7.4.3.1. CHINA 19
7.4.3.1.1. CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 19
7.4.3.1.2. CHINA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 19
7.4.3.2. INDIA 19
7.4.3.2.1. INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 19
7.4.3.2.2. INDIA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 19
7.4.3.3. JAPAN 19
7.4.3.3.1. JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 19
7.4.3.3.2. JAPAN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($MILLION) 19
7.4.3.4. ROAPAC 19
7.4.3.4.1. ROAPAC MARKET ESTIMATES AND FORECASTS 2012-2022($MILLION) 20
7.4.3.4.2. ROAPAC MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022($MILLION) 20
7.5. REST OF THE WORLD 20
7.5.1. REST OF THE WORLD MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 20
7.5.2. REST OF THE WORLD MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 20
7.5.3. REST OF THE WORLD MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 20
7.5.3.1. LATIN AMERICA 20
7.5.3.1.1. LATIN AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 20
7.5.3.1.2. LATIN AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 20
7.5.3.2. MIDDLE EAST AND AFRICA 20
7.5.3.2.1. MIDDLE EAST AND AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 20
7.5.3.2.2. MIDDLE EAST AND AFRICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 20
CHAP 8. COMPETITIVE LANDSCAPE 21
8.1. ABBOTT LABORATORIES 22
8.1.1. COMPANY OVERVIEW 22
8.1.2. SCOT ANALYSIS 22
8.1.3. PRODUCT BENCHMARKING 22
8.1.4. STRATEGIC INITIATIVES 22
8.2. ARJOHUNTLEIGH, INC. 22
8.2.1. COMPANY OVERVIEW 22
8.2.2. SCOT ANALYSIS 22
8.2.3. PRODUCT BENCHMARKING 22
8.2.4. STRATEGIC INITIATIVES 22
8.3. BAXTER INTERNATIONAL INC. 22
8.3.1. COMPANY OVERVIEW 22
8.3.2. SCOT ANALYSIS 22
8.3.3. PRODUCT BENCHMARKING 22
8.3.4. STRATEGIC INITIATIVES 22
8.4. BAYER AG 22
8.4.1. COMPANY OVERVIEW 22
8.4.2. SCOT ANALYSIS 22
8.4.3. PRODUCT BENCHMARKING 22
8.4.4. STRATEGIC INITIATIVES 22
8.5. BIO-RAD LABORATORIES 22
8.5.1. COMPANY OVERVIEW 22
8.5.2. SCOT ANALYSIS 22
8.5.3. PRODUCT BENCHMARKING 22
8.5.4. STRATEGIC INITIATIVES 22
8.6. CSL BEHRING 22
8.6.1. COMPANY OVERVIEW 22
8.6.2. SCOT ANALYSIS 22
8.6.3. PRODUCT BENCHMARKING 23
8.6.4. STRATEGIC INITIATIVES 23
8.7. DELTEX MEDICAL 23
8.7.1. COMPANY OVERVIEW 23
8.7.2. SCOT ANALYSIS 23
8.7.3. PRODUCT BENCHMARKING 23
8.7.4. STRATEGIC INITIATIVES 23
8.8. GF HEALTH PRODUCTS 23
8.8.1. COMPANY OVERVIEW 23
8.8.2. SCOT ANALYSIS 23
8.8.3. PRODUCT BENCHMARKING 23
8.8.4. STRATEGIC INITIATIVES 23
8.9. HAEMONETICS CORP. 23
8.9.1. COMPANY OVERVIEW 23
8.9.2. SCOT ANALYSIS 23
8.9.3. PRODUCT BENCHMARKING 23
8.9.4. STRATEGIC INITIATIVES 23
8.10. HOLOGIC INC. 23
8.10.1. COMPANY OVERVIEW 23
8.10.2. SCOT ANALYSIS 23
8.10.3. PRODUCT BENCHMARKING 23
8.10.4. STRATEGIC INITIATIVES 23
8.11. LFB GROUP 23
8.11.1. COMPANY OVERVIEW 23
8.11.2. SCOT ANALYSIS 23
8.11.3. PRODUCT BENCHMARKING 23
8.11.4. STRATEGIC INITIATIVES 23
8.12. NOVO NORDISK A/S 24
8.12.1. COMPANY OVERVIEW 24
8.12.2. SCOT ANALYSIS 24
8.12.3. PRODUCT BENCHMARKING 24
8.12.4. STRATEGIC INITIATIVES 24
8.13. OCTAPHARMA AG 24
8.13.1. COMPANY OVERVIEW 24
8.13.2. SCOT ANALYSIS 24
8.13.3. PRODUCT BENCHMARKING 24
8.13.4. STRATEGIC INITIATIVES 24
8.14. PFIZER 24
8.14.1. COMPANY OVERVIEW 24
8.14.2. SCOT ANALYSIS 24
8.14.3. PRODUCT BENCHMARKING 24
8.14.4. STRATEGIC INITIATIVES 24
8.15. ROCHE HOLDING LTD. 24
8.15.1. COMPANY OVERVIEW 24
8.15.2. SCOT ANALYSIS 24
8.15.3. PRODUCT BENCHMARKING 24
8.15.4. STRATEGIC INITIATIVES 24
TABLE 1 GLOBAL BLOOD MARKET BY APPLICATION 2012-2022 ($ MILLION) 24
TABLE 2 GLOBAL DERMATOLOGY MARKET 2012-2022 ($ MILLION) 24
TABLE 3 GLOBAL DIABETES MARKET 2012-2022 ($ MILLION) 24
TABLE 4 GLOBAL GASTROENTEROLOGY MARKET 2012-2022 ($ MILLION) 24
TABLE 5 GLOBAL INTRACRANIAL MONITORING IN STROKE AND BRAIN INJURY MARKET 2012-2022 ($ MILLION) 25
TABLE 6 GLOBAL PERIPHERAL VASCULAR DISEASES MARKET 2012-2022 ($ MILLION) 25
TABLE 7 GLOBAL TUMOUR MONITORING AND ANGIOGENESIS MARKET 2012-2022 ($ MILLION) 25
TABLE 8 GLOBAL BLOOD MARKET BY PRODUCT 2012-2022 ($ MILLION) 25
TABLE 9 GLOBAL ELECTROMAGNETIC BLOOD FLOWMETERS MARKET 2012-2022 ($ MILLION) 25
TABLE 10 GLOBAL LASER DOPPLER BLOOD FLOWMETERS MARKET 2012-2022 ($ MILLION) 25
TABLE 11 GLOBAL ULTRASONIC DOPPLER BLOOD FLOWMETERS MARKET 2012-2022 ($ MILLION) 25
TABLE 12 NORTH AMERICA GLOBAL BLOOD MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ MILLION) 25
TABLE 13 NORTH AMERICA GLOBAL BLOOD MARKET ESTIMATES AND FORECAST BY REGION 2012 – 2022 ($ MILLION) 25
TABLE 14 NORTH AMERICA GLOBAL BLOOD MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ MILLION) 25
TABLE 15 U.S. GLOBAL BLOOD MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ MILLION) 25
TABLE 16 U.S. GLOBAL BLOOD MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ MILLION) 25
TABLE 17 CANADA GLOBAL BLOOD MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ MILLION) 25
TABLE 18 CANADA GLOBAL BLOOD MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 –2022 ($ MILLION) 25
TABLE 19 CANADA GLOBAL BLOOD MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ MILLION) 25
TABLE 20 EUROPE GLOBAL BLOOD MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ MILLION) 25
TABLE 21 EUROPE GLOBAL BLOOD MARKET ESTIMATES AND FORECAST BY REGION 2012 – 2022 ($ MILLION) 25
TABLE 22 EUROPE GLOBAL BLOOD MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ MILLION) 26
TABLE 23 GERMANY GLOBAL BLOOD MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ MILLION) 26
TABLE 24 GERMANY METABOLOMICS TECHNOLOGY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ MILLION) 26
TABLE 25 UK GLOBAL BLOOD MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ MILLION) 26
TABLE 26 UK GLOBAL BLOOD MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ MILLION) 26
TABLE 27 ASIA PACIFIC GLOBAL BLOOD MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ MILLION) 26
TABLE 28 ASIA PACIFIC GLOBAL BLOOD MARKET ESTIMATES AND FORECAST BY REGION 2012 – 2022 ($ MILLION) 26
TABLE 29 ASIA PACIFIC GLOBAL BLOOD MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ MILLION) 26
TABLE 30 CHINA GLOBAL BLOOD MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ MILLION) 26
TABLE 31 CHINA GLOBAL BLOOD MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ MILLION) 26
TABLE 32 INDIA GLOBAL BLOOD MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ MILLION) 26
TABLE 33 INDIA GLOBAL BLOOD MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ MILLION) 26
TABLE 34 JAPAN GLOBAL BLOOD MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ MILLION) 26
TABLE 35 JAPAN GLOBAL BLOOD MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ MILLION) 26
TABLE 36 MIDDLE EAST & AFRICA GLOBAL BLOOD MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ MILLION) 26
TABLE 37 MIDDLE EAST & AFRICA GLOBAL BLOOD MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ MILLION) 26
TABLE 38 LATIN AMERICA GLOBAL BLOOD MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ MILLION) 26
TABLE 39 LATIN AMERICA GLOBAL BLOOD MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ MILLION) 27
FIGURE 1 MARKET SHARE BY REGIONS 27
FIGURE 2 UNITED STATES MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 27
FIGURE 3 CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 27
FIGURE 4 MEXICO MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 27
FIGURE 5 EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 27
FIGURE 6 GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 27
FIGURE 7 UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 27
FIGURE 8 FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 27
FIGURE 9 APAC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 27
FIGURE 10 CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 27
FIGURE 11 INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 27
FIGURE 12 JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 27
FIGURE 13 MIDDLE EAST & AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 27
FIGURE 14 LATIN AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 27
Choose License
Contact Information
: sales@briskinsights.com
: +448081890034 (UK)